New Key Statistics Module, Z-Score and F-Score
AMEX:CANF Key Ratios
| Market Cap $ M | 11.94 |
| Enterprise Value $ M | 7.27 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.33 |
| Price/Sales | 8.67 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -3.00 |
| Beneish M-Score | -3.5 |
| 10-y EBITDA Growth Rate % | 35.60 |
| 5-y EBITDA Growth Rate % | 49.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.97 |
| EV-to-EBITDA | -0.97 |
| PEG | -- |
| Shares Outstanding M | 6.10 |
| Net Margin (%) | -1,026.98 |
| Operating Margin % | -1,102.47 |
| Pre-tax Margin (%) | -1,026.98 |
| Quick Ratio | 2.93 |
| Current Ratio | 2.93 |
| ROA % (ttm) | -84.56 |
| ROE % (ttm) | -146.59 |
| ROIC % (ttm) | -806.95 |
| Dividend Yield % | -- |
| Altman Z-Score | -38.19 |
CANF Number of Guru Trades
CANF Volume of Guru Trades
Gurus Latest Trades with AMEX:CANF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:CANF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Can Fite Biofarma Ltd Insider Transactions
No Available Data
News about AMEX:CANF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers